Market open

Fortress Biotech/FBIO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Fortress Biotech

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Ticker

FBIO
Trading on

Industry

Biotechnology

Employees

186

Fortress Biotech Metrics

BasicAdvanced
$43M
Market cap
-
P/E ratio
-$3.67
EPS
1.81
Beta
-
Dividend rate
$43M
1.81
$4.95
$1.24
646K
1.369
1.15
-568.167
-605.713
-10.20%
-36.41%
704.33%
0.259
2.01
-45.81
-0.198
31.68%
-76.92%
16.20%
-16.36%

What the Analysts think about Fortress Biotech

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Fortress Biotech stock.

Fortress Biotech Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Fortress Biotech Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy FBIO

$

Sign up or log in to buy
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Fortress Biotech stock?

Fortress Biotech (FBIO) has a market cap of $43M as of October 08, 2024.

What is the P/E ratio for Fortress Biotech stock?

The price to earnings (P/E) ratio for Fortress Biotech (FBIO) stock is 0 as of October 08, 2024.

Does Fortress Biotech stock pay dividends?

No, Fortress Biotech (FBIO) stock does not pay dividends to its shareholders as of October 08, 2024.

When is the next Fortress Biotech dividend payment date?

Fortress Biotech (FBIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Fortress Biotech?

Fortress Biotech (FBIO) has a beta rating of 1.81. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.